ArticleNutrients2025

Genetic Variants, Bioactive Compounds, and PCSK9 Inhibitors in Hyper-LDL-Cholesterolemia: A GWAS and In Silico Study on Cardiovascular Disease Risk.

Meiling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.